Akèy › Mesotelyom
Etid klinik pou Mesotelyom ap rekrite nan Etazini
45 etid pou Mesotelyom ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX15 etid
- New York City, NY10 etid
- Chicago, IL9 etid
- Washington, DC9 etid
- Nashville, TN8 etid
- Boston, MA8 etid
- Philadelphia, PA6 etid
- Los Angeles, CA6 etid
- Pittsburgh, PA6 etid
- Seattle, WA6 etid
- Arlington, VA6 etid
- Edison, NJ5 etid
- Rochester, MN5 etid
- Columbus, OH5 etid
- Dallas, TX4 etid
- San Antonio, TX4 etid
- St. Louis, MO4 etid
- Omaha, NE4 etid
- Queens, NY4 etid
- San Diego, CA4 etid
- Tampa, FL4 etid
- Jacksonville, FL4 etid
- Phoenix, AZ4 etid
- Miami, FL3 etid
- Denver, CO3 etid
- Grand Rapids, MI3 etid
- New Rochelle, NY3 etid
- East Norwalk, CT3 etid
- Greenburgh, NY3 etid
- Staten Island, NY3 etid
- Mountain View, CA3 etid
- Detroit, MI3 etid
- Santa Rosa, CA3 etid
- Fort Worth, TX3 etid
- Durham, NC3 etid
- Santa Monica, CA3 etid
Pa eta
- Arizona7 etid
- Colorado8 etid
- Florid12 etid
- Georgia3 etid
- Illinois11 etid
- Kalifòni12 etid
- Kansas3 etid
- Maryland10 etid
- Massachusetts10 etid
- Michigan6 etid
- Minnesota8 etid
- Missouri5 etid
- Nebraska4 etid
- New Jersey8 etid
- New York11 etid
- North Carolina4 etid
- Ohio9 etid
- Pennsylvania13 etid
- Tennessee8 etid
- Texas19 etid
- Utah4 etid
- Virginia8 etid
- Washington6 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT04431024A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04981119A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06057935Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Ap rekrite
Laj 30 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06037941Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
Ap rekriteFaz 2
Laj 18 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT05960773Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Ap rekriteEtid obsèvasyon
Laj 2 a 120 · Tout sèks · Mizajou Sep 23, 2026 · NCT00242723A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07705334Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06566079TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04969315Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05245500SW-682 in Advanced Solid Tumors
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06251310Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Ap rekriteEtid obsèvasyon
Laj 2 a 100 · Tout sèks · Mizajou Sep 1, 2026 · NCT01950572Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Aug 26, 2026 · NCT06885697Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Ap rekriteEtid obsèvasyon
Laj 2 a 120 · Tout sèks · Mizajou Aug 26, 2026 · NCT03830229A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Aug 4, 2026 · NCT07192900Lead-212 PSV359 Therapy for Patients With Solid Tumors
Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou Jul 6, 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT05568680CT-95 in Advanced Cancers Associated With Mesothelin Expression
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06756035A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06051695A Study of Sacituzumab Govitecan in People With Mesothelioma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 28, 2026 · NCT06477419Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.